How many studies have been conducted on Cd56 Antigen?

BiohacksAI has indexed 81 PubMed studies on Cd56 Antigen, including 2 randomized controlled trials (RCTs). 57% of studies involve human subjects.

What are the main research areas for Cd56 Antigen?

The primary research domains for Cd56 Antigen are 🔬 Oncology, 🛡️ Immunity, 🧬 Hormones. This is based on analysis of 81 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Cd56 Antigen

The 140 kDa isoform of NCAM (neural cell adhesion molecule) containing a transmembrane domain and short cytoplasmic tail. It is expressed by all lymphocytes mediating non-MHC restricted cytotoxicity and is present on some neural tissues and tumors.

81+ PubMed studies analyzed · 2 RCTs · Evidence Score: 46.4

Research Domains

Cd56 Antigen has been studied across 14 research domains including 🔬 Oncology, 🛡️ Immunity, 🧬 Hormones, 🔬 Inflammation, 😴 Sleep. The primary research focus is 🔬 Oncology with 65% of studies addressing this area.

Loading evidence profile...

This evidence profile for Cd56 Antigen is generated deterministically from 81 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.